{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T06:51:01Z","timestamp":1760079061371,"version":"3.40.5"},"reference-count":19,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,3,1]]},"abstract":"<jats:p>Cutaneous herpes simplex virus type 2 (HSV-2) infection was recognized at 19 days of age in a 1415-g female infant born at 31 weeks of gestation. Cerebrospinal fluid (CSF) HSV polymerase chain reaction (PCR) was negative, and MRI of the brain was normal. After a 14-day course of high-dose intravenous acyclovir, the infant developed a cutaneous recurrence at 38 days of age. CSF HSV PCR again was negative. She was subsequently begun on oral acyclovir to prevent cutaneous reactivation of HSV. At 3 months of age, the infant developed HSV encephalitis as manifested by fever, seizures, abnormal CSF indices, abnormal brain MRI, and positive CSF HSV PCR. No cutaneous disease was present. It is not known whether the HSV encephalitis in our patient represented reactivation of previously unrecognized central nervous system infection or new onset of central nervous system disease as a result of spread from other tissue or site to the brain. The failure of oral acyclovir to prevent such an occurrence, however, highlights gaps in our understanding of the pathogenesis of neonatal HSV disease and questions the use of acyclovir suppression to prevent neurologic sequelae.<\/jats:p>","DOI":"10.1542\/peds.2004-0777","type":"journal-article","created":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T19:22:35Z","timestamp":1109704955000},"page":"804-809","source":"Crossref","is-referenced-by-count":34,"title":["Herpes Simplex Virus Encephalitis During Suppressive Therapy With Acyclovir in a Premature Infant"],"prefix":"10.1542","volume":"115","author":[{"given":"Monica","family":"Fonseca-Aten","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison F.","family":"Messina","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan S.","family":"Jafri","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo J.","family":"Sa\u0301nchez","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2005,3,1]]},"reference":[{"key":"2021121011180009600_R1","unstructured":"Arvin AMW, Richard J. Herpes simplex virus infections. In: Remington JSK, Jerome O, eds. Infectious Diseases of the Fetus and Newborn Infant. 5th ed. Philadelphia, PA: Saunders; 2001"},{"key":"2021121011180009600_R2","doi-asserted-by":"crossref","unstructured":"Kimberlin DW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics.\u20082001;108:223\u2013229","DOI":"10.1542\/peds.108.2.223"},{"key":"2021121011180009600_R3","doi-asserted-by":"crossref","unstructured":"Whitley R, Arvin A, Prober C, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med.\u20081991;324:444\u2013449","DOI":"10.1056\/NEJM199102143240703"},{"key":"2021121011180009600_R4","doi-asserted-by":"crossref","unstructured":"Whitley R, Arvin A, Prober C, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med.\u20081991;324:450\u2013454","DOI":"10.1056\/NEJM199102143240704"},{"key":"2021121011180009600_R5","doi-asserted-by":"crossref","unstructured":"Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics.\u20082001;108:230\u2013238","DOI":"10.1542\/peds.108.2.230"},{"key":"2021121011180009600_R6","doi-asserted-by":"crossref","unstructured":"Gutman LT, Wilfert CM, Eppes S. Herpes simplex virus encephalitis in children: analysis of cerebrospinal fluid and progressive neurodevelopmental deterioration. J Infect Dis.\u20081986;154:415\u2013421","DOI":"10.1093\/infdis\/154.3.415"},{"key":"2021121011180009600_R7","doi-asserted-by":"crossref","unstructured":"Kohl S. A hypothesis on the pathophysiology of neonatal herpes simplex virus encephalitis: clinical recurrence after asymptomatic primary infection. Pediatr Infect Dis J.\u20081990;9:307\u2013308","DOI":"10.1097\/00006454-199005000-00001"},{"key":"2021121011180009600_R8","doi-asserted-by":"crossref","unstructured":"Kimberlin D, Powell D, Gruber W, et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I\/II trial. Pediatr Infect Dis J.\u20081996;15:247\u2013254","DOI":"10.1097\/00006454-199603000-00014"},{"key":"2021121011180009600_R9","doi-asserted-by":"crossref","unstructured":"Mandyla H, Anagnostakis D, Koutsovitis P, Siahanidou T, Youroukos S. Late recurrence of herpes simplex virus meningoencephalitis in two infants. Eur J Pediatr.\u20082001;160:732\u2013735","DOI":"10.1007\/s004310100848"},{"key":"2021121011180009600_R10","doi-asserted-by":"crossref","unstructured":"Kimberlin DW, Lakeman FD, Arvin AM, et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis.\u20081996;174:1162\u20131167","DOI":"10.1093\/infdis\/174.6.1162"},{"key":"2021121011180009600_R11","unstructured":"American Academy of Pediatrics. Herpes simplex. In: Pickering LK, ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003:344\u2013353"},{"key":"2021121011180009600_R12","doi-asserted-by":"crossref","unstructured":"Koelfen W, Freund M, Guckel F, Rohr H, Schultze C. MRI of encephalitis in children: comparison of CT and MRI in the acute stage with long-term follow-up. Neuroradiology.\u20081996;38:73\u201379","DOI":"10.1007\/BF00593228"},{"key":"2021121011180009600_R13","doi-asserted-by":"crossref","unstructured":"Diamond C, Mohan K, Hobson A, Frenkel L, Corey L. Viremia in neonatal herpes simplex virus infections. Pediatr Infect Dis J.\u20081999;18:487\u2013489","DOI":"10.1097\/00006454-199906000-00002"},{"key":"2021121011180009600_R14","doi-asserted-by":"crossref","unstructured":"Whitley RJ, Gnann JW, Jr. Acyclovir: a decade later. N Engl J Med.\u20081992;327:782\u2013789","DOI":"10.1056\/NEJM199209103271108"},{"key":"2021121011180009600_R15","unstructured":"Rabalais GP, Nusinoff-Lehrman S, Arvin AM, Levin MJ. Antiviral susceptibilities of herpes simplex virus isolates from infants with recurrent mucocutaneous lesions after neonatal infection. Pediatr Infect Dis J.\u20081989;8:221\u2013223"},{"key":"2021121011180009600_R16","doi-asserted-by":"crossref","unstructured":"Nyquist AC, Rotbart HA, Cotton M, et al. Acyclovir-resistant neonatal herpes simplex virus infection of the larynx. J Pediatr.\u20081994;124:967\u2013971","DOI":"10.1016\/S0022-3476(05)83194-4"},{"key":"2021121011180009600_R17","doi-asserted-by":"crossref","unstructured":"Oram RJ, Marcellino D, Strauss D, et al. Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate. J Infect Dis.\u20082000;181:1458\u20131461","DOI":"10.1086\/315387"},{"key":"2021121011180009600_R18","doi-asserted-by":"crossref","unstructured":"Levin MJ, Weinberg A, Leary JJ, Sarisky RT. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum. Pediatr Infect Dis J.\u20082001;20:1094\u20131097","DOI":"10.1097\/00006454-200111000-00021"},{"key":"2021121011180009600_R19","doi-asserted-by":"crossref","unstructured":"Gutierrez K, Arvin AM. Long term antiviral suppression after treatment for neonatal herpes infection. Pediatr Infect Dis J.\u20082003;22:371\u2013372","DOI":"10.1097\/01.inf.0000064120.03600.cb"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/3\/804\/1020117\/zpe00305000804.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/3\/804\/1020117\/zpe00305000804.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:14:27Z","timestamp":1639181667000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/115\/3\/804\/67248\/Herpes-Simplex-Virus-Encephalitis-During"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,3,1]]},"published-print":{"date-parts":[[2005,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-0777","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2005,3,1]]}}}